Generation Bio Reports Recent Business Highlights and Third Quarter 2024 Financial Results
GBIO Stock | USD 1.16 0.03 2.52% |
About 64% of Generation Bio's investor base is looking to short. The analysis of the overall investor sentiment regarding Generation Bio Co suggests that many traders are alarmed. Generation Bio's investing sentiment overview a quick insight into current market opportunities from investing in Generation Bio Co. Many technical investors use Generation Bio stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Generation |
Non-human primate data presented at ESGCT demonstrated selective in vivo delivery of mRNA with T cell-targeted lipid nanoparticle Cash balance of 199.8 million expected to fund operations into 2H 2027 CAMBRIDGE, Mass., Nov. 06, 2024 -- Generation Bio Co. , a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, reported business highlights and third quarter 2024 financial results. There is immense potential
Read at finance.yahoo.com
Generation Bio Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Generation Bio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Generation Bio Fundamental Analysis
We analyze Generation Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Generation Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Generation Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
Generation Bio is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Generation Bio Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Generation Bio stock to make a market-neutral strategy. Peer analysis of Generation Bio could also be used in its relative valuation, which is a method of valuing Generation Bio by comparing valuation metrics with similar companies.
Peers
Generation Bio Related Equities
NKTX | Nkarta | 2.18 | ||||
CCCC | C4 Therapeutics | 1.39 | ||||
NUVB | Nuvation Bio | 0.76 | ||||
EWTX | Edgewise Therapeutics | 1.88 | ||||
KRON | Kronos Bio | 2.00 | ||||
STOK | Stoke Therapeutics | 2.11 | ||||
IPSC | Century Therapeutics | 2.40 | ||||
PASG | Passage Bio | 2.56 | ||||
ERAS | Erasca | 2.66 | ||||
GLUE | Monte Rosa | 2.95 | ||||
STTK | Shattuck Labs | 5.00 | ||||
SANA | Sana Biotechnology | 7.35 | ||||
LYEL | Lyell Immunopharma | 11.84 |
Check out Generation Bio Hype Analysis, Generation Bio Correlation and Generation Bio Performance. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Generation Bio. If investors know Generation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Generation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.19) | Revenue Per Share 0.28 | Quarterly Revenue Growth 2.52 | Return On Assets (0.19) | Return On Equity (0.86) |
The market value of Generation Bio is measured differently than its book value, which is the value of Generation that is recorded on the company's balance sheet. Investors also form their own opinion of Generation Bio's value that differs from its market value or its book value, called intrinsic value, which is Generation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Generation Bio's market value can be influenced by many factors that don't directly affect Generation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Generation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Generation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Generation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.